Literature DB >> 1915382

Review of Citrobacter bacteremia in cancer patients over a sixteen-year period.

G Samonis1, E Anaissie, L Elting, G P Bodey.   

Abstract

A review was conducted of 65 episodes of Citrobacter bacteremia in cancer patients during a 16-year period. Cases of polymicrobial bacteremia were excluded from this analysis. The infection occurred most commonly in patients with acute leukemia. Most patients acquired the infection in the hospital, and 57% had received antibiotic therapy during the preceding ten days. Fever occurred in 98% of cases and shock in 17%. Thirty-eight percent of patients had concomitant pneumonia. Patients with shock, pneumonia or hemorrhage had a substantially poorer prognosis. The response rate was 72% for patients who received appropriate antibiotics. Patients who continued to have positive blood culture results while receiving appropriate antibiotic therapy had a poor prognosis. Beta-lactam antibiotics were more effective than aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915382     DOI: 10.1007/bf01963933

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  41 in total

Review 1.  Citrobacter meningitis and brain abscess in infancy: epidemiology, pathogenesis, and treatment.

Authors:  M W Kline
Journal:  J Pediatr       Date:  1988-09       Impact factor: 4.406

2.  [Neonatal sepsis and urinary tract infection due to Citrobacter diversus].

Authors:  S Weizer; D Heldenberg
Journal:  Harefuah       Date:  1986-04-01

3.  Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.

Authors:  S C Schimpff; H Gaya; J Klastersky; M H Tattersall; S H Zinner
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

4.  Citrobacter diversus at Grace Hospital, Detroit, Michigan.

Authors:  A Madrazo; J Geiger; C B Lauter
Journal:  Am J Med Sci       Date:  1975 Nov-Dec       Impact factor: 2.378

5.  Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome.

Authors:  V Drelichman; J D Band
Journal:  Arch Intern Med       Date:  1985-10

6.  Increasing incidence of Gram-positive sepsis in cancer patients.

Authors:  P A Pizzo; S Ladisch; R M Simon; F Gill; A S Levine
Journal:  Med Pediatr Oncol       Date:  1978

7.  Aztreonam therapy in neutropenic patients with cancer.

Authors:  P G Jones; K V Rolston; V Fainstein; L Elting; R S Walters; G P Bodey
Journal:  Am J Med       Date:  1986-08       Impact factor: 4.965

8.  Clinical significance of citrobacter isolates.

Authors:  G R Hodges; C E Degener; W G Barnes
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

Review 9.  Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Authors:  B E Kreger; D E Craven; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

10.  Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

Authors:  J C Wade; S C Schimpff; K A Newman; P H Wiernik
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

View more
  5 in total

1.  Endogenous endophthalmitis caused by Citrobacter koseri originating from a renal abscess.

Authors:  Jeremy He Cong'En; Mijan Miah; Benjamin Sünkel-Laing; Julian Emmanuel
Journal:  BMJ Case Rep       Date:  2014-08-05

Review 2.  Bifocal cervical spondylodiscitis due to Citrobacter diversus.

Authors:  A Sotto; J C Bernard; C Brunschwig; D Blin; F M Lopez; B Combe
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

3.  Citrobacter infections in a general hospital: characteristics and outcomes.

Authors:  G Samonis; D E Karageorgopoulos; D P Kofteridis; D K Matthaiou; V Sidiropoulou; S Maraki; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-06       Impact factor: 3.267

4.  Gram-negative bacteremia in non-neutropenic patients: a 3-year review.

Authors:  A Gikas; G Samonis; A Christidou; J Papadakis; D Kofteridis; Y Tselentis; N Tsaparas
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

5.  Citrobacter koseri Pneumonia As Initial Presentation of Underlying Pulmonary Adenocarcinoma.

Authors:  Kelly Pennington; Martin Van Zyl; Patricio Escalante
Journal:  Clin Med Insights Case Rep       Date:  2016-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.